General Biotechnology

Achieving optimal financial and strategic transaction outcomes for small to mid-sized privately funded start-ups

Non-dilutive funding and equity capital are two key reasons why life sciences companies pursue strategic partnerships. In fact alliances are also strong contributors to successful “exits”, whether Mergers and Acquisitions (M&A) (~ 40% of partn…

Achieving optimal financial and strategic transaction outcomes for small to mid-sized privately funded start-ups Read Post »

Biotechblog
Scroll to Top